Osiris Therapeutics, Inc. engages in the research, development, manufacture, and commercialization of regenerative medicine products. Its biosurgery business focuses on using unique tissue preservation technologies to develop viable human tissue products designed to improve wound closure and surgical outcomes for patients and physicians over standard of care alone. The company was founded by Peter A. Friedli and James S. Burns on December 23, 1992 and is headquartered in Columbia, MD.

Taiga Biotechnologies is a clinical-stage company focused on harnessing the immune system to fight infectious disease and cancer. The company's Bone Marrow Engraftment Enhancer (BMEE) program is developing a first-line product, TBX-1400, to enhance the engraftment of hematopoietic stem and progenitor cells during an allogeneic hematopoietic stem cell transplant (HSCT). Taiga Biotechnologies lead Cell-Based Immunotherapy product candidate, TBX-3400, uses a patient’s own immune cells to help fight against cancer and infectious disease. TBX-3400 is an autologous cell product made from peripheral blood mononuclear cells that are treated ex vivo with our fusion protein and then delivered intravenously back to the patient the following day. They developing technologies to generate red blood cells in the laboratory for clinical applications and products to improve the utility of red blood cell products.

Thyas Co., Ltd. is a company headquartered in Kyoto, Japan, that develops immuno-cell therapy for cancer and infectious diseases. The firm was founded in 2015 by Shin Kaneko. Yasumichi Hitoshi is currently the CEO of the company.

Nippon Menard Cosmetic Co. Ltd. develops cosmetic and health products. They manufacture and distributes cosmetics such as make-ups and perfumes, and also health food, and undergarments. The company was established in November 11, 1959 and is based in Aichi, Japan.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Hangzhou Yuanyuan Biotechnology Co., Ltd., established on 2018-02-08, Business scope includes technology development,Technical Services,technical consulting,Achievement transfer:Biotechnology,medical technology(The above except pharmaceuticals,Hazardous chemicals and precursor chemicals);Sales:First,two,Class III Medical Devices,Experimental consumables,Chemical products and raw materials(Except for the above dangerous chemicals and precursor chemicals)**(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients. Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia, due to Low- or Intermediate-1-risk Myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Revlimid is sold through proprietary risk-management distribution programs, to ensure safe and appropriate use of these pharmaceuticals. Vidaza is approved for the treatment of patients with MDS.

KOTAI Biotechnologies is a research base that represents immunological bioinformatics and information structural analysis. They conduct research and development with institutions and universities, as well as with business companies such as pharmaceutical companies. They provide for the development of diagnostic and treatment methods. From a routine blood sample, platform technology can reveal the structure and function of immune cell receptors with unprecedented resolution. Repertoire Builder can group receptors according to their target epitopes using sequence and structural features from B or T cell receptor models, revealing the functional landscape of a donor and quantifying differences between donors.

Pingtan Shenyan Biotechnology Co., Ltd., established on 2021-04-22, Business scope includes general items:Research and development of bio-based materials technology;Medical Research and Experimental Development;Human stem cell technology development and application;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D and application of cell technology;Health Consulting Services(Does not include medical services);Information Consulting Service(Not including licensing information consulting services);business management;Cosmetics Retail;Cosmetics Wholesale;Sales of hygiene products and single-use medical products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shandong Xingrui Biotechnology Co., Ltd., established on 2014-03-27, The scope of business includes the development of new technologies for biological cell incubation,Biological cell and gene related technology development,Technical testing,Technical Services,technology transfer,Promotion and related technical consultation;Provide medical aesthetic technical services;sell cosmetics,skin care products,Instrumentation,medical instruments,Laboratory Reagent Consumables;Undertake indoor and outdoor decoration and decoration projects,civil Engineering,Waterproofing,plumbing(without pressure piping),Indoor and outdoor insulation engineering construction.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Wuhan Life Technology Co., Ltd., established on 2008-02-01, Business scope includes licensed projects:pharmaceutical production;Drug retail;Production of Class II Medical Devices;Production of Class III Medical Devices;Drug import and export;Import and export;Drug internet information service;Internet Information Service for Medical Devices(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class II Medical Devices;Health Consulting Services(Does not include medical services);Medical Research and Experimental Development(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Shenzhen Zhongxu Biotechnology Co., Ltd., established on 2021-03-08, Business scope includes general business items:Biotechnology R&D;Sanitation products,Class I medical device,daily necessities,Cosmetic technology development and sales;Import of goods and technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product sales(No licensed chemical products);Domestic trade agent;Sales of daily chemical products.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:Sales of Class II medical supplies and equipment.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Usai Life Technology Co., Ltd., established on 2018-10-29, The scope of business includes storage services for biological products(Business activities involving licenses);Biomaterials Research,to develop,technical consulting,technology transfer,Technical Services;cell therapy technology,cell antibody,Gene drug development,Technical Services,Technology Promotion,technical consulting;Technology development of genetic engineering,Technology Promotion,technical consulting,technology transfer;laboratory reagent(Does not contain dangerous goods),No. I,R&D and sales of Class II medical devices;Self-operated and agent goods and technology import and export;Basic medical research services;Clinical Medical Research Services;Clinical Laboratory Services;Pharmaceutical Research Services;for-profit medical institution(Carry out business activities with a license);R&D and sales of cosmetics;production of biological products,Sales;Health Advisory;Health Checkup Service;Technology development and sales of health food(Carry out business activities with a license);Enterprise Management Services(Carry out business activities with a license).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Cell Valley (Nanjing) Biotechnology Co., Ltd., established on 2019-01-17, Business scope includes licensed projects:Class III medical device business;pharmaceutical production;Production of Class II Medical Devices;Production of Class III Medical Devices;accommodation service;Inspection and testing service;food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Healthy food(prepackaged)Sales;Sales of Class II Medical Devices;Cosmetics Retail;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information Consulting Service(Not including licensing information consulting services);Sales of office equipment consumables;R&D and application of cell technology;Engineering and Technology Research and Experimental Development;Business Management Consulting;Specialty Chemicals Sales(Free of Hazardous Chemicals);Artificial intelligence public service platform technical consulting services;Technology promotion and application services;Experimental analysis instrument sales;Machinery and Equipment Leasing;housing lease;property management;Conference and Exhibition Services;Technology intermediary service;business management;Sales of formula food for special medical purposes;General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)